The Novo Nordisk Pregnancy Registry study is sponsored and funded by Novo Nordisk, with Imperial College Healthcare NHS Trust as the participating organisation conducting the study.
Join the study to help researchers, healthcare professionals, and other patients learn about the safety of using weight loss medications during pregnancy. A pregnancy registry is a study that collects health information from women who take prescription medicines when they are pregnant.
You do not need to be on a weight loss medication to be eligible for this study.
You may be eligible if you are a pregnant woman who is:
And have been diagnosed with either:
BMI (Body Mass Index) is a measure of your weight in relation to your height.
Enrol in the RegistryFor more information on the Novo Nordisk Pregnancy Registry, or to learn more about your eligibility to participate, you can:
Complete the Contact Request Form and a Registry team member will contact you
Call the study phone number* at
07551 298403
(Monday-Friday, 8:30-5:00)
*normal costs apply
Future pregnant women, their healthcare professional, and researchers can benefit from the information you provide to the registry.
If you are eligible and would like to participate, you will be asked to:
You and your healthcare professional will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms, via the website portal or via short phone interviews with one of the registry staff members. Only information normally documented in your medical record will be collected.
If you participate, there will be:
If you are eligible and would like to participate, you will be asked to provide information to the registry at enrolment and periodically throughout your pregnancy: